AYTU Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Aytu Biopharma Inc

Watchlist Manager

Watchlist

Price: 2.2 USD 1.38% Market Closed

Market Cap: $23.6m

	Aytu Biopharma Inc NASDAQ:AYTU	US
M	Metso Oyj OMXH:METSO	FI
	Multiplan Empreendimentos Imobiliarios SA BOVESPA:MULT3	BR
P	Pattern Group Inc NASDAQ:PTRN	US
S	Satra Properties (India) Ltd BSE:508996	IN
S	Surteco Group SE F:SUR	DE
	Nicco Parks & Resorts Ltd BSE:526721	IN
M	My Screen Mobile Inc OTC:MYSL	CA
A	Amplia Therapeutics Ltd OTC:INNMF	AU
A	AXMIN Inc OTC:AXMIF	CA
	Axel Mark Inc TSE:3624	JP
	Built Cybernetics PLC LSE:BUC	UK
Q	Qualcomm Inc BMV:QCOM	US
	Skane mollan AB STO:SKMO	SE
K	KH Vatec Co Ltd KOSDAQ:060720	KR
R	Reach PLC SWB:MRR	UK

Profitability Summary

Aytu Biopharma Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

64%

Strong 3Y Average Gross Margin

67%

Gross Margin is Increasing

62% > 64%

Negative Operating Margin

-14%

Negative 3Y Average Operating Margin

-4%

Operating Margin is Increasing

-16% > -14%

Negative Net Margin

-25%

Negative 3Y Average Net Margin

-22%

Declining Net Margin

-24% > -25%

Healthy Free Cash Flow Margin

Negative 3Y Average Free Cash Flow Margin

-1%

Free Cash Flow Margin is Increasing

4% > 6%

Negative ROE

-53%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-4%

ROIC is Increasing

-18% > -12%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.